To conclude, mitochondrial glucocorticoid receptor overexpression contributes to the enhancement of HepG2 aggressiveness in the induction of tumor growth and progression, which is accompanied by reduced OXPHOS biosynthesis, reduction in PDH activity, and alterations in the Krebs cycle and glucose metabolism. This evidence concerns the gene PDP1 and neoplasm.